Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

NCT01707394 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism

Interventions

DRUG: Apixaban

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]